We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Leaky Calcium Channels Promote Development of Diabetes

By LabMedica International staff writers
Posted on 19 Apr 2015
Print article
Image: Electron microscope image of a pancreatic beta cell, showing malformed mitochondria resulting from calcium leakage; the purple circle represents an insulin granule (Photo courtesy of Dr. Gaetano Santulli, Columbia University Medical Center).
Image: Electron microscope image of a pancreatic beta cell, showing malformed mitochondria resulting from calcium leakage; the purple circle represents an insulin granule (Photo courtesy of Dr. Gaetano Santulli, Columbia University Medical Center).
Chronic leakage from cellular calcium channels has been linked to a rare type of exercise-induced cardiac arrest and has been shown to cause glucose intolerance, suggesting that it might be involved in the development of type II diabetes.

RyR2 (type 2 ryanodine receptor) is a Ca2+ release channel protein on the endoplasmic reticulum (ER) of several types of cells, including cardiomyocytes and pancreatic beta-cells. In cardiomyocytes, RyR2-dependent Ca2+ release is critical for excitation-contraction coupling; however, a functional role for RyR2 in beta-cell insulin secretion and diabetes mellitus has yet to be determined.

To clarify the functional role of RyR2 in diabetes, investigators at Columbia University Medical Center (New York, NY, USA) took advantage of rare RyR2 mutations that were identified in patients with a genetic form of exercise-induced sudden death (catecholaminergic polymorphic ventricular tachycardia [CPVT]). As these mutations resulted in a “leaky” RyR2 channel, the investigators exploited them to assess RyR2 channel function in beta-cell dynamics.

They reported in the April 6, 2015, online edition of the Journal of Clinical Investigation that CPVT patients with mutant leaky RyR2 displayed glucose intolerance, which previously had not been diagnosed in patients with this syndrome. In mice, transgenic expression of CPVT-associated RyR2 resulted in impaired glucose homeostasis. An in-depth evaluation of pancreatic islets and beta-cells from these animals revealed intracellular Ca2+ leak via oxidized and nitrosylated RyR2 channels, activated ER stress response, mitochondrial dysfunction, and decreased fuel-stimulated insulin release.

Small molecule Rycal compounds were shown to enhance the binding of calstabin to leaky RyRs, repairing the leak and restoring normal function. Calstabin-2, which forms part of the RyR2 complex, helps to maintain the closed state of the channel during the diastolic phase of the cardiac cycle. However, in patients with heart failure, and in CPVT, depletion of calstabin-2 from the RyR2 complex caused calcium leakage that could trigger fatal ventricular tachyarrhythmia. By stabilizing RyR2, it may be possible to restore the strength of muscle contraction or neuronal function in chronic diseases.

"The advantage of a Rycal is that many drugs now used to treat type II diabetes increase the risk for low blood sugar and for heart disease," said senior author Dr. Andrew R. Marks, professor of physiology and cellular biophysics at Columbia University Medical Center. "Based on the mechanism of action of Rycals, we would not expect this drug to cause either of these. Also, Rycals are currently being tested in patients with heart disease and muscle disorders and have a good safety record so far."

"We have known that calcium in the pancreatic beta-cells plays a significant role in regulating insulin secretion, but calcium levels were thought to be controlled largely by the entry of calcium into the cell," said Dr. Marks. "It turns out that there is another mechanism in pancreatic beta-cells that also controls calcium. This mechanism involves RyR2 channels, and leaks in these channels can lead to impaired glucose tolerance. These findings open up a whole new area of research into the molecular underpinnings of pre-diabetes and diabetes and point to potential therapeutic targets."

Related Links:
Columbia University Medical Center


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.